跳至主要内容
临床试验/KCT0002704
KCT0002704招募中未知

A Study on Depression Related Indicators of Healthy Women

Korea Institute of Oriental Medicine0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
20(Year) 至 65(Year)(—)
性别
Female

入选标准

  • 1) Women aged 20 to 65 years
  • 2) The Korean Hamilton Depression Rating Scale score is less than 7
  • 3) Those who can make sufficient communication and questionnaire
  • 4) Decide on voluntary participation and sign the written agreement

排除标准

  • 1) People with a medical condition that may affect the degree of depression (eg, myocardial infarction, brain tumor, multiple sclerosis, hyperthyroidism, hyperparathyroidism, Addison's disease, Cushing's disease, rheumatoid arthritis, Vascular disease, epilepsy, etc.)
  • 2) Those who have undergone medical surgery or treatment within 1 month of the start of clinical research
  • 3) Those who have had acute and chronic infectious diseases for the last 2 weeks
  • 4) Those who had excessive diet control for disease-related or weight control purposes within one week of the start of clinical studies
  • 5) Those who are taking periodical medicines by internal medicine, surgery, psychiatric diagnosis at the time of starting the clinical study, and those who are thought to be able to influence the autonomic nervous system and depressive symptom manifestations (eg anxiolytics, antidepressants, L-dopa, Digitalis, bromide, cyclosporin, disulfiram, isoniazid, yohimbine, etc.)
  • 6) Those who have been diagnosed with medical or psychiatric disorders and have not been informed about clinical symptoms or biochemical indicators
  • 7) Those with chronic diseases that are not well controlled by appropriate treatment (chronic active hepatitis, hypertension, diabetes, etc.)
  • 8) Those who are treated with liver cancer or liver cirrhosis, chronic renal failure, congestive heart failure, etc.
  • 9) Those who are pregnant or are pregnant or are lactating
  • 10) AST or ALT exceeds 2 times the upper limit of the reference range, or Total Bilirubin exceeds 2 times the upper limit of the reference range
  • 11) Patients with renal impairment (Cockcroft-Gault-type creatinine clearance less than 50 mL / min
  • 12) Alcohol or other substance Abuse / Dependence or history
  • 13) Those who participated in other clinical studies with intervention within one month before the start of the study
  • 14) Those who do not understand the consent because of mental retardation and intellectual problems, or are unable to continue the research
  • 15) Those who have communication difficulties that are difficult to follow the directions of the researcher
  • 16) Any other person who is considered to be ineligible to take the test

研究者

相似试验